EQRx to trim more than 40 staffers in restructuring maneuver
Three months after putting on hold its ambitious plan to bring low-cost, innovative drugs to the US market, EQRx is shedding jobs.
The biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
